Diagnostic role of p63 immunostaining in fine needle aspiration cytology of different breast lesions

Acta Cytologica

Volumn 55, Issue 2, 2011, Pages 149-157

  Aiad, Hayam Abdel Samie ^a   Abd El Halim Kandil, Mona ^a   Abd El Wahed, Moshira Mohammed ^a   Abdou, Asmaa Gaber ^a   Hemida, Aiat Shaban ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Breast cancer; Cytology; p63 immunostaining

Indexed keywords

PROTEIN P63; TP63 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; ASPIRATION CYTOLOGY; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST LESION; CARCINOMA IN SITU; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; KAPPA STATISTICS; MAMMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR CELL; BREAST; BREAST TUMOR; CELL AGGREGATION; EPITHELIUM CELL; METABOLISM; NEEDLE BIOPSY; PATHOLOGY; REPRODUCIBILITY;

ADULT; BIOPSY, FINE-NEEDLE; BREAST; BREAST NEOPLASMS; CELL AGGREGATION; CELL NUCLEUS; EPITHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; REPRODUCIBILITY OF RESULTS; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 79955669644     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000323313     Document Type: Article

References (28)

1. Mokhtar N, Gouda I, Adel I: Breast cancer; in Mokhtar N, Gouda I, Adel I (eds): Cancer Pathology Registry, 2003-2004, and Time Trend Analysis. Cairo, Elsheraa, 2007, chapter 4, pp 40-45.
2. Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, Kardum-Skelin I, Kloboves- Prevodnik V, Krishnamurthy S, Koutselini H, Majak B, Olszewski W, Onal B, Pohar- Marinsek Z, Shabalova I, Smith J, Tani E, Vielh P, Wiener H, Schenck U, Schmitt F: The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology 2008; 19: 271-278.
3. Werling RW, Hwang H, Yaziji H, Gown AM: Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Am J Surg Pathol 2003; 27: 82-90.
4. McKee GT, Tambouret RH, Finkelstein D: Fine-needle aspiration cytology of the breast: invasive vs. in situ carcinoma. Diagn Cytopathol 2001; 25: 73-77.
5. Pattari SK, Dey P, Gupta SK, Joshi K: Myoepithelial cells: any role in aspiration cytology smears of breast tumors? Cytojournal 2008; 5: 9.
6. Nagao T, Bando Y, Sasa M, Morimoto T, Sano N, Hirose T, Tangoku A: False-positives in fine-needle aspiration cytology of breast disease can be reduced with p63 immunostaining - a preliminary report. Anticancer Res 2006; 26: 4373-4377.
7. Foschini MP, Scarpellini F, Gown AM, Eusebi V: Differential expression of myoepithelial markers in salivary, sweat and mammary glands. Int J Surg Pathol 2000; 8: 29-37.
8. Otterbach F, Bànkfalvi A, Bergner S, Decker T, Krech R, Boecker W: Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast. Histopathology 2000; 37: 232-240.
9. Moritani S, Kushima R, Sugihara H, Bamba M, Kobayashi TK, Hattori T: Availability of CD10 immunohistochemistry as a marker of breast myoepithelial cells on paraffin sections. Mod Pathol 2002; 15: 397-405.
10. Reis-Filho JS, Albergaria A, Milanezi F, Amendoeira I, Schmitt FC: Naked nuclei revisited: p63 immunoexpression. Diagn Cytopathol 2002; 27: 135-138.
11. Stefanou D, Batistatou A, Nonni A, Arkoumani E, Agnantis NJ: p63 expression in benign and malignant breast lesions. Histol Histopathol 2004; 19: 465-471.
12. Wang HH, Ducatman BS: Fine needle aspiration of the breast. A probabilistic approach to diagnosis of carcinoma. Acta Cytol 1998; 42: 285-289.
13. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer. I. The value of histologic grades in breast cancer. Experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-410.
14. Shidham VB, Lindholm PF, Kajdacsy-Balla A, Chang CC, Komorowski R: Methods of cytologic smear preparation and fixation. Effect on the immunoreactivity of commonly used anticytokeratin antibody AE1/AE3. Acta Cytol 2000; 44: 1015-1022.
15. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC: Distribution of p63, a novel myoepithelial marker, in fine-needle aspiration biopsies of the breast: an analysis of 82 samples. Cancer 2003; 99: 172-179.
16. Harton AM, Wang HH, Schnitt SJ, Jacobs TW: p63 Immunocytochemistry improves accuracy of diagnosis with fine-needle aspiration of the breast. Am J Clin Pathol 2007; 128: 80-85.
17. Chan YH: Biostatistics 104: correlational analysis. Singapore Med J 2003; 44: 614-619.
18. Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, Pohar K, Hoos A, Cordon-Cardo C: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002; 8: 494-501.
19. Chaiwun B, Sukhamwang N, Lekawanvijit S, Sukapan K, Rangdaeng S, Muttarak M, Thorner PS: Atypical and suspicious categories in fine needle aspiration cytology of the breast: histological and mammographical correlation and clinical significance. Singapore Med J 2005; 46: 706-709.
20. Bak M, Szabó E, Mándoky L: The 'gray zone' in fine needle aspiration cytology of the breast. Magy Seb 2005; 58: 3-7.
21. Ariga R, Bloom K, Reddy VB, Kluskens L, Francescatti D, Dowlat K, Siziopikou P, Gattuso P: Fine-needle aspiration of clinically suspicious palpable breast masses with histopathologic correlation. Am J Surg 2002; 184: 410-413.
22. Yeoh GP, Chan KW: Fine needle aspiration of breast masses: an analysis of 1533 cases in private practice. Hong Kong Med J 1998; 4: 283-288.
23. Jensen ML, Johansen P, Noer H, et al: Ductal adenoma of the breast: the cytological features of six cases. Diagn Cytopathol 1994; 10: 143-145.
24. Lakhani SR, O'Hare MJ: The mammary myoepithelial cell - Cinderella or ugly sister? Breast Cancer Res 2001; 3: 1-4.
25. Jones C, Nonni AV, Fulford L, Merrett S, Chaggar R, Eusebi V, Lakhani SR: CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation. Br J Cancer 2001; 85: 422-427.
26. Reis-Filho JS, Milanezi F, Amendoeira I, Albergaria A, Schmitt FC: p63 staining of myoepithelial cells in breast fine needle aspirates: a study of its role in differentiating in situ from invasive ductal carcinomas of the breast. J Clin Pathol 2002; 55: 936-939.
27. Barbareschi M, Pecciarini L, Cangi MG, Macrì E, Rizzo A, Viale G, Doglioni C: p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast. Am J Surg Pathol 2001; 25: 1054-1060.
28. Kaufmann O, Fietze E, Mengs J, Dietel M: Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001; 116: 823-830.